Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference39 articles.
1. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells;B Liao;J Biol Chem,2005
2. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein;F Mueller-Pillasch;Oncogene,1997
3. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma;YM Jeng;Hepatology,2008
4. IMP-3 is a novel progression marker in malignant melanoma;JG Pryor;Mod Pathol,2008
5. IMP-3 expression in melanocytic lesions;L Yu;J Cutan Pathol,2010
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin‐like growth factor 2 mRNA‐binding protein 3 enhanced melanoma migration through regulation of AKT1 and RELA expression;Experimental Dermatology;2024-01
2. Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry;Cancers;2022-05-07
3. Expression of IMP3 in a retrospective cohort of melanomas with selective lymph node biopsy;Dermatologic Therapy;2020-11
4. Mutational profiling of melanomas in patients from the southeast coast of China;Translational Cancer Research;2020-08
5. IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives;Frontiers in Cell and Developmental Biology;2020-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3